GSK232802

DB16110InvestigationalSmall molecule

GSK232802 is under investigation in clinical trial NCT00604825 (Treatment of Hot Flashes/flushes in Postmenopausal Women (WARM Study)).

Mechanism: Pharmacologically active on Sodium-dependent noradrenaline transporter and Sodium-dependent serotonin transporter
Curator reviewed
Formula / weight: C₂₄H₂₈O₃ · 364.485 g/mol (avg)
Code names: GSK-232802

Resolves to

Compound

Structure

InChIKeyKNQLNDPHLXIOCY-UHFFFAOYSA-NSMILESCC1(C)CC(CC(C)(C)C1)=C(C1=CC=C(O)C=C1)C1=CC=C(C=C1)C(O)=O

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with GSK232802, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.